ecteinascidin 743 has been researched along with Alveolar Soft Part Sarcoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blay, JY; Boye, K; Brahmi, M; Casali, PG; Duffaud, F; Fedenko, A; Gelderblom, H; Hindi, N; Italiano, A; Kawai, A; Kobayashi, E; Kosela, H; Le Cesne, A; Maki, RG; Martin-Broto, J; Mir, O; Patel, S; Provenzano, S; Rutkowski, P; Somaiah, N; Stacchiotti, S; Sundby Hall, K; Vincenzi, B | 1 |
| Croué, A; Pavageau, AH; Reguerre, Y; Rialland, X; Rousselet, MC | 1 |
| Verweij, J | 1 |
| Bertz-Lepel, J; Bitz, U; Busemann, C; Pink, D; Reichardt, P | 1 |
4 other study(ies) available for ecteinascidin 743 and Alveolar Soft Part Sarcoma
| Article | Year |
|---|---|
Activity of Pazopanib and Trabectedin in Advanced Alveolar Soft Part Sarcoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Female; Follow-Up Studies; Humans; Indazoles; Male; Middle Aged; Prognosis; Pyrimidines; Retrospective Studies; Sarcoma, Alveolar Soft Part; Sulfonamides; Survival Rate; Trabectedin | 2018 |
[A rare tumour with a distinctive histological appearance].
Topics: Adolescent; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Arteriovenous Malformations; Bevacizumab; Biomarkers, Tumor; Combined Modality Therapy; Dactinomycin; Desmin; Diagnosis, Differential; Dioxoles; Doxorubicin; Humans; Ifosfamide; Leg; Lung Neoplasms; Male; Neoplasm Proteins; Prognosis; S100 Proteins; Sarcoma, Alveolar Soft Part; Soft Tissue Neoplasms; Staining and Labeling; Tetrahydroisoquinolines; Trabectedin; Vincristine | 2010 |
Alveolar soft part sarcoma: should we be targeting the tumor or targeting the vasculature?
Topics: Dioxoles; Humans; Male; Sarcoma, Alveolar Soft Part; Tetrahydroisoquinolines; Trabectedin | 2012 |
Efficacy of trabectedin in patients with advanced or metastatic alveolar soft-part sarcoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents, Alkylating; Dioxoles; Humans; Male; Middle Aged; Sarcoma, Alveolar Soft Part; Tetrahydroisoquinolines; Trabectedin; Treatment Outcome; Young Adult | 2012 |